Q2 2020 13F Holders as of 30 Jun 2020
-
Type / Class
-
Equity / BIOTECHNOLOGY
-
Total 13F shares
-
910,704
-
Share change
-
-67,378
-
Total reported value
-
$53,116,808
-
Price per share
-
$58.27
-
Number of holders
-
75
-
Value change
-
-$2,922,278
-
Number of buys
-
29
-
Number of sells
-
28
Institutional Holders of INVESCO EXCHANGE TRADED FD T - BIOTECHNOLOGY (PBE) as of Q2 2020
As of 30 Jun 2020 INVESCO EXCHANGE TRADED FD T - BIOTECHNOLOGY (PBE) had 75 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 910,704 shares of stock of the company.
Largest 10 holders included MORGAN STANLEY, ROYAL BANK OF CANADA, UBS Group AG, WELLS FARGO & COMPANY/MN, BANK OF AMERICA CORP /DE/, ADVISOR GROUP HOLDINGS, INC., Anfield Capital Management, LLC, SUSQUEHANNA INTERNATIONAL GROUP, LLP, PFG Advisors, and YHB Investment Advisors, Inc..
This table shows 75 institutional shareholders of the security as of 30 Jun 2020.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.